Kosuke Okada

3.1k total citations
125 papers, 2.5k citations indexed

About

Kosuke Okada is a scholar working on Epidemiology, Molecular Biology and Surgery. According to data from OpenAlex, Kosuke Okada has authored 125 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 32 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Kosuke Okada's work include Liver Disease Diagnosis and Treatment (19 papers), Herpesvirus Infections and Treatments (13 papers) and T-cell and Retrovirus Studies (11 papers). Kosuke Okada is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Herpesvirus Infections and Treatments (13 papers) and T-cell and Retrovirus Studies (11 papers). Kosuke Okada collaborates with scholars based in Japan, United States and Egypt. Kosuke Okada's co-authors include Junichi Shoda, Kan-ichi OHSHIMA, Tetsuro Ishii, Masanobu GORYO, Eiji Warabi, Masayuki Yamamoto, Hirotoshi Utsunomiya, Jun Sasaki, Keiko Taguchi and M Oguro and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Kosuke Okada

116 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kosuke Okada Japan 26 1.1k 698 649 299 258 125 2.5k
David G. Besselsen United States 32 1.2k 1.1× 330 0.5× 609 0.9× 341 1.1× 414 1.6× 83 3.0k
David T. Kiang United States 34 1.2k 1.0× 631 0.9× 1.1k 1.7× 186 0.6× 548 2.1× 87 3.5k
Ying Wu China 37 2.5k 2.2× 1.1k 1.6× 346 0.5× 396 1.3× 438 1.7× 102 4.4k
Andrés Piñeiro Spain 32 1.6k 1.4× 230 0.3× 270 0.4× 828 2.8× 147 0.6× 76 3.2k
Anne Roulston Canada 24 1.9k 1.7× 505 0.7× 648 1.0× 1.1k 3.8× 288 1.1× 42 3.5k
Steven Vonderfecht United States 34 2.0k 1.8× 655 0.9× 408 0.6× 494 1.7× 749 2.9× 88 4.1k
Andreas Henke Germany 28 843 0.7× 469 0.7× 163 0.3× 526 1.8× 712 2.8× 73 2.5k
Jerry A. Peterson United States 27 1.5k 1.3× 301 0.4× 407 0.6× 701 2.3× 289 1.1× 72 3.2k
Kenneth S. S. Chang United States 19 679 0.6× 287 0.4× 231 0.4× 418 1.4× 301 1.2× 54 1.6k
Hideki Aizaki Japan 42 1.7k 1.5× 2.9k 4.2× 286 0.4× 527 1.8× 700 2.7× 113 5.5k

Countries citing papers authored by Kosuke Okada

Since Specialization
Citations

This map shows the geographic impact of Kosuke Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke Okada more than expected).

Fields of papers citing papers by Kosuke Okada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosuke Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke Okada. The network helps show where Kosuke Okada may publish in the future.

Co-authorship network of co-authors of Kosuke Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Kosuke Okada. A scholar is included among the top collaborators of Kosuke Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosuke Okada. Kosuke Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mukherjee, Pradipta, Shin‐ichi Fukuda, Kosuke Okada, et al.. (2022). Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography. Biomedical Optics Express. 13(7). 4071–4071. 1 indexed citations
3.
Okada, Kosuke, Seiya Tanaka, Eiji Warabi, et al.. (2022). Antioxidative Self-Assembling Nanoparticles Attenuate the Development of Steatohepatitis and Inhibit Hepatocarcinogenesis in Mice. Antioxidants. 11(10). 1939–1939. 5 indexed citations
4.
Kim, Taeho, Sechang Oh, Takashi Shida, et al.. (2021). Relationships of Dietary Habits and Physical Activity Status with Non-Alcoholic Fatty Liver Disease Featuring Advanced Fibrosis. International Journal of Environmental Research and Public Health. 18(17). 8918–8918. 8 indexed citations
5.
Okada, Kosuke, Eiji Warabi, Fumihiko Uchida, et al.. (2021). Prevention of non‐alcoholic steatohepatitis by long‐term exercise via the induction of phenotypic changes in Kupffer cells of hyperphagic obese mice. Physiological Reports. 9(9). e14859–e14859. 8 indexed citations
6.
Yoshida, Yukihiro, Kosuke Okada, Shigeru Makino, et al.. (2011). Reflect-array Antenna for Receiving of Satellite Broadcasting. IEICE Technical Report; IEICE Tech. Rep.. 111(172). 37–42. 2 indexed citations
7.
Okada, Kosuke, Junichi Shoda, Keiko Taguchi, et al.. (2009). Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems. Biochemical and Biophysical Research Communications. 389(3). 431–436. 73 indexed citations
8.
Okada, Kosuke, Junichi Shoda, Keiko Taguchi, et al.. (2008). Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 295(4). G735–G747. 123 indexed citations
9.
GORYO, Masanobu, et al.. (2008). Intussusception of the Proventriculus in Chicks. Journal of the Japan Veterinary Medical Association. 61(4). 299–302. 2 indexed citations
10.
GORYO, Masanobu, et al.. (2005). Pathological and Experimental Studies of Giant Facial Masses in Commercial Layer Hens. Journal of the Japan Veterinary Medical Association. 58(10). 671–675. 2 indexed citations
11.
Takahashi, Kazuhiro, Kosuke Okada, Jae‐Heon Kang, et al.. (2005). A lineage of hepatitis E virus within genotype IV, associated with severe forms of hepatitis. Kanzo. 46(6). 389–390. 13 indexed citations
12.
A, Bán, M. Takahashi, H. Ishikawa, et al.. (2002). Hereditary and Clinico-pathological Examinations of PCLN-1/Claudin-16 Deficiency in Japanese Black Cattle in the Touhoku Region. 25(1). 1–10. 3 indexed citations
13.
Taniguchi, K., et al.. (1999). Development of A Novel Monoclonal Antibody, TAG2, to The Neutrophil-Specific Antigen NA2.. Journal of the Japan Society of Blood Transfusion. 45(5). 629–631. 1 indexed citations
14.
Sasaki, Jun, et al.. (1998). An Outbreak of Cholangiohepatitis due to Clostridium perfringens in Broiler Chickens. Journal of the Japan Veterinary Medical Association. 51(9). 528–532. 5 indexed citations
15.
Koyama, Masato, Masanobu GORYO, Satoshi Chiba, & Kosuke Okada. (1997). Diplomyelia in a Calf. Journal of the Japan Veterinary Medical Association. 50(3). 153–156. 4 indexed citations
16.
GORYO, Masanobu, et al.. (1995). Two Cases of Equine Mycotic Epistaxis. Journal of the Japan Veterinary Medical Association. 48(8). 547–550. 1 indexed citations
17.
Tsuda, Hiroyuki, Kiyoshi Takatsuki, R Ohno, et al.. (1994). Treatment of adult T-cell leukaemia–lymphoma with irinotecan hydrochloride (CPT-11). British Journal of Cancer. 70(4). 771–774. 63 indexed citations
18.
Okada, Kosuke & Koji Hatano. (1992). One case each of rubella and rubeola keratoconjunctivitis. 46(12). 1577–1579. 1 indexed citations
19.
Igawa, Mikio, et al.. (1990). M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy for advanced bladder cancer. 52(4). 442–447. 1 indexed citations
20.
Oguro, M, Yasuo Seki, Kosuke Okada, & T Andoh. (1990). Collateral drug sensitivity induced in CPT-11 (a novel derivative of camptothecin)-resistant cell lines. Biomedicine & Pharmacotherapy. 44(4). 209–216. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David G. Besselsen Breakdown of academic impact, for papers by David T. Kiang Breakdown of academic impact, for papers by Ying Wu Breakdown of academic impact, for papers by Andrés Piñeiro Breakdown of academic impact, for papers by Anne Roulston Breakdown of academic impact, for papers by Steven Vonderfecht Breakdown of academic impact, for papers by Andreas Henke Breakdown of academic impact, for papers by Jerry A. Peterson Breakdown of academic impact, for papers by Kenneth S. S. Chang Breakdown of academic impact, for papers by Hideki Aizaki
Rankless by CCL
2026